Supplementary Table S2 from Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer

Abstract

Supplemental Table S2. Characteristics of patients who underwent both cfDNA and tumor tissue genotyping testing.</p